Atlas Trials

Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma

Clinical trial NCT00746590 · TERMINATED

Trial details

NCT number
NCT00746590
Sponsor
BTG International Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2008-09-01
Primary completion
2009-06-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.